The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preoperative CA 19-9 and CEA as predictors of operative outcomes in resectable gastric cancer (GC).
 
Alexandra Gangi
No Relationships to Disclose
 
John David
No Relationships to Disclose
 
Michelle Guan
No Relationships to Disclose
 
Veronica Placencio-Hickok
Patents, Royalties, Other Intellectual Property - Patent 17814046.3-1111 PCT/US2017037558. Bhowmick NA, Placencio V, Agarwal A., Smith B. Sensitization of tumors to therapies through endoglin antagonism (Inst)
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Ipsen; Novartis; Perthera
Travel, Accommodations, Expenses - Halozyme
 
Samuel Jacob Klempner
Stock and Other Ownership Interests - TP Therapeutics
Consulting or Advisory Role - Astellas Pharma; Boston Biomedical; Foundation Medicine; Lilly
Speakers' Bureau - Foundation Medicine
Research Funding - Astellas Pharma (Inst); Leap Therapeutics (Inst)
 
Miguel Burch
Consulting or Advisory Role - Applied medical
Travel, Accommodations, Expenses - Intuitive Surgical
 
Joseph Chao
Consulting or Advisory Role - AstraZeneca (Inst); Boston Biomedical; Five Prime Therapeutics; Lilly; Merck
Speakers' Bureau - Merck
Research Funding - Merck (Inst); Novonco Therapeutics (Inst)
 
Mitchell Kamrava
Honoraria - Augmenix
 
Richard Tuli
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
 
Jun Gong
No Relationships to Disclose